AC
CELG

Argentiere Capital’s Celgene Corp CELG Stock Holding History

Argentiere Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-80,000
Closed -$7.55M – 37
2019
Q1 		$7.55M Buy
+80,000
New +$7M 3.28% 6
2017
Q1 		– Sell
-21,140
Closed -$2.45M – 95
2016
Q4 		$2.45M Buy
+21,140
New +$2.35M 1.15% 23

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Argentiere Capital's CELG Position: Q2 2019 in Review

Argentiere Capital sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 80,000 shares — an estimated $7.55M sold.

Argentiere Capital first reported a position in CELG in Q4 2016 and held it in 2 quarters. The position peaked at $7.55M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Argentiere Capital reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Argentiere Capital sold 80,000 Celgene Corp shares in Q2 2019, an estimated $7.55M.
  • Argentiere Capital first reported a position in Celgene Corp in Q4 2016 and held it in 2 quarters.
  • Argentiere Capital's Celgene Corp position peaked at $7.55M in Q1 2019.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Argentiere Capital's 13F filing for Q2 2019, filed 14 Aug 2019.